43s On World Pancreatic Cancer Day, we honor our late co-founder Anne Glauber. Let's Win exists because of her commitment that no one should face a pancreatic cancer diagnosis without resources and hope. Her legacy lives on in every person we reach. đź’ś letswinpc.org/about-us #WorldPancreaticCancerDay 0 views
24s Ten years of progress. A future full of possibility. 💜 Our co-founder and CEO, Cindy Price Gavin, reflects on Let’s Win’s 10th anniversary and progress in new treatments. Through Nov 10, gifts are matched up to $100K, doubling your impact: letswinpc.org/donate #LetsWinPC 0 views
63s Next up in our "Why I'm Running" series: Michael. He's running the TCS New York City Marathon in honor of Dr. Marta RendĂłn, who passed away from pancreatic cancer and was the mother of his close friend Juan Pellerano-RendĂłn. . Support Michael's run: https://bit.ly/4yxtBnB 0 views
63s About 10% of pancreatic cancer patients have neuroendocrine tumors (PNETs). How are they different? Dr. Diane Reidy-Lagunes of Duke University Health System joins Alisyn Camerota on PancChat to explain diagnosis, treatment, and why expertise matters. 🎧 youtu.be/zSltAxo1w0M #OncSky #PancChat 0 views
58s Durante este Mes de la Herencia Hispana, el Dr. Dean Xerras, miembro de la junta de Let's Win y médico de atención primaria, explica por qué los recursos en español son esenciales para los pacientes y las familias que enfrentan el cáncer de páncreas. 0 views
26s Up to 95% of pancreatic cancer patients have a KRAS mutation, long thought undruggable. Dr. Eileen O'Reilly of Memorial Sloan Kettering explains what changed and what Rasonque™ (daraxonrasib) means for patients. 🎧 youtu.be/vu0CWLzsusU #PancChat #OncSky 0 views
30–50% of pancreatic cancer patients have diabetes or prediabetes at diagnosis, and 40% more develop it during treatment. On the new PancChat, Dr. Afreen Shariff joins host Alisyn Camerota to talk about managing both — and why your care team needs to know your numbers. New episode is out now 🎧 0 views